Tosun Halil, Akınsal Emre Can, Sönmez Gökhan, Baydilli Numan, Demirci Deniz
Department of Urology, Erciyes University Medıcal Faculty, Kayseri, Türkiye.
Ther Clin Risk Manag. 2024 Nov 30;20:811-816. doi: 10.2147/TCRM.S478919. eCollection 2024.
To assess the effectiveness and safety of high-intensity focused electromagnetic technology (HIFEM) used as a therapeutic approach in patients with stress and mixed urinary incontinence.
Thirty-five females suffering from stress and mixed urinary incontinence were included in the study. The electromagnetic chair (BTL EMSELLA) was applied to the patient's pelvic area twice a week for 28 minutes, totaling 6 sessions. The patients' "International Consultation on Incontinence Questionnaire-Short Form" (ICIQ-SF) scores and the number of daily absorbent pad usage were recorded. Results were evaluated after the sixth session and at a first-month follow-up.
The average ICIQ-SF score at baseline was 10.18 ± 4.19 (ranging from 2-18) which declined to 5.33 ± 3.97 after six sessions, and further improved to 4.26 ± 3.94 points at the one-month follow-up. After six sessions, an average improvement of 52.06% in ICIQ-SF score was observed, and after one month of follow-up, an average improvement of 59.6% was detected, which was found to be statistically significant (p=0.038). In addition, the mean number of pads used per day decreased to 1.25 ± 1.54 after treatment, a significant improvement was observed, and the mean daily pad use decreased further to 0.91 ± 1.11 at the first-month follow-up.
HIFEM has demonstrated in our study its ability to safely and effectively treat female patients suffering from stress and mixed urinary incontinence, as evidenced by significant improvements in symptoms and quality of life observed in clinical trials.
评估高强度聚焦电磁技术(HIFEM)作为一种治疗方法用于压力性和混合性尿失禁患者的有效性和安全性。
本研究纳入了35名患有压力性和混合性尿失禁的女性。将电磁椅(BTL EMSELLA)应用于患者的盆腔区域,每周两次,每次28分钟,共6次治疗。记录患者的“国际尿失禁咨询问卷简表”(ICIQ-SF)评分及每日使用吸收性尿垫的数量。在第6次治疗后及首次随访1个月时评估结果。
基线时ICIQ-SF评分的平均值为10.18±4.19(范围为2 - 18),6次治疗后降至5.33±3.97,在1个月随访时进一步改善至4.26±3.94分。6次治疗后,ICIQ-SF评分平均改善52.06%,随访1个月后,平均改善59.6%,差异有统计学意义(p = 0.038)。此外,治疗后每日使用尿垫的平均数量降至1.25±1.54,有显著改善,在1个月随访时每日尿垫平均使用量进一步降至0.91±1.11。
在我们的研究中,HIFEM已证明其能够安全有效地治疗患有压力性和混合性尿失禁的女性患者,临床试验中观察到的症状和生活质量的显著改善证明了这一点。